<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">
Log In

SmartTRAK Life Sciences News and Analysis Blog

2 min read

Perfuze: Building, Innovating and Simplifying Stroke Care

4/28/25 10:10 AM

Wayne Allen

Perfuze CEO Wayne Allen discusses the company, its novel technology and how the company plans to capture share in the US Market for Mechanical Thrombectomy Devices in an interview with SmartTRAK. 

To see the full interview, click on the following video (32:35 min). An outline of the interview by timecode and a link to download a transcript of the interview are provided below.


Interview Topics by Timecode: 

00:07 Perfuze CEO Wayne Allen discusses his background, the company and its mission.
03:26 Overview of Perfuze technology and products.
07:05 Regulatory approvals and clinical research
08:43 Status of MARRS IDE Study and future plans. Seeking a standalone thrombectomy indication.
11:08 Differentiating Millipede 088 Catheter and competing in the market.
15:40 Status of Millipede 088’s limited market release in the US, commercial strategy, and obtaining real-world insights.
19:29 Funding and timeline to finance and accelerate commercial expansion, clinical, R&D initiatives and pipeline.
21:18 Long-term goals, future innovations/indications and growth.
24:47 Strategic vision, capturing share and market positioning.
27:13 Addressing uncertainties, supply chain challenges, tariffs and future outlook.
28:46 What’s next for Perfuze and closing remarks.
 
Click the button below to download the complete transcript of our interview with Perfuze CEO Wayne Allen, in which he discusses his company, its novel technology and strategies for growth in the US Market for Mechanical Thrombectomy. Anne Staylor, SmartTRAK Executive Editor, VP & GM of Neuro Therapies, conducted the interview.Download the Transcript

SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s proprietary methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK has to offer and see how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.
 
 
Anne Staylor
Written by Anne Staylor

Former Senior Editor, Medtech Insight. +25 years in various leadership roles in business intelligence, marketing, communications, product management, and consulting for medical device industry, hospitals, physician groups, insurers. Registered nurse and former Director of Marketing for a national ambulatory surgery company.

  • There are no suggestions because the search field is empty.

Follow Us on Social Media

Recent Articles